( MENAFN - EIN Presswire) Spravato® (esketamine) has been approved for use as a standalone treatment for depression, without the requirement of an accompanying antidepressant. Legal Disclaimer: ...

Initial recessions include a 2022 order to test Medicare and Medicaid models to lower healthcare costs. (Reuters) The Food and Drug Administration approved Johnson & Johnson’s nasal spray for adults ...

You can get in touch with Aliss by emailing [email protected]. Languages: English. Medicaid is the largest federal government program providing medical and health-related services to low ...

Elon Musk's Department of Government Efficiency representatives are at the Centers for Medicare & Medicaid Services this week examining payment and contracting systems of federal health agency.

Representatives of billionaire Elon Musk’s Department of Government Efficiency (DOGE) have turned their focus to the Centers for Medicare and Medicaid Services (CMS), the agency confirmed Wednesday.

Republicans in Congress have begun discussing possible changes to Medicaid — the public health insurance program for low-income and disabled Americans that covers 80 million people. Those ...

Liberal lawmakers and advocates are moving to shield the Medicaid program from potential cuts under the Trump administration, pledging to resist major changes to the safety-net health program that ...

Known as Home and Community-Based Services (HCBS) waivers, the programs—now in their fourth decade—are funded by Medicaid and run by each individual state. With potential cuts to Medicaid a ...

Liberal advocacy groups are ramping up efforts to protect the Medicaid program from potential cuts by Republican lawmakers and the new Trump administration. The Democratic group Protect Our Care ...

The comments suggested that the Trump administration was likely to seek a broad overhaul of how the federal government administers Medicaid, the joint federal-state health insurance program for ...

Credit: Johnson & Johnson. The approval of Spravato for the monotherapy indication in TRD was supported by data from the randomized, double-blind, placebo-controlled, phase 4 TRD4005 trial.